PB-28
PB-28 is a sigma receptor agonist, with a strong selectivity for the sigma-2 receptor. It is used in scientific research.
Pharmacology[edit | edit source]
PB-28 is a potent sigma receptor agonist, with a strong selectivity for the sigma-2 receptor. It has a Ki of 0.68 nM at the sigma-2 receptor, and 137 nM at the sigma-1 receptor. PB-28 is an antagonist at the alpha-1 adrenergic receptor and the 5-HT2A receptor, but with much lower affinity than for the sigma-2 receptor.
Chemistry[edit | edit source]
PB-28 is a cyclohexylpiperazine derivative, structurally related to the drug clozapine.
Research[edit | edit source]
PB-28 has been studied for its potential use in the treatment of cancer, due to its ability to trigger apoptosis in tumor cells.
See also[edit | edit source]
References[edit | edit source]
PB-28 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD